Clinical Trial Update: Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing hepatic safety of Kaletra-based vs Nevirapine-based antiretroviral regimens in HIV/HCV co-infected patients; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Kaletra (lopinavir)
• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 4 | Status: TERMINATED